Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Dec 10;37(4):e0008724.
doi: 10.1128/cmr.00087-24. Epub 2024 Nov 4.

American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis

Affiliations
Meta-Analysis

American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis

Robert L Sautter et al. Clin Microbiol Rev. .

Abstract

SUMMARYBlood cultures (BCs) are one of the critical tests used to detect bloodstream infections. BC results are not 100% specific. Interpretation of BC results is often complicated by detecting microbial contamination rather than true infection. False positives due to blood culture contamination (BCC) vary from 1% to as high as >10% of all BC results. False-positive BC results may result in patients undergoing unnecessary antimicrobial treatments, increased healthcare costs, and delay in detecting the true cause of infection or other non-infectious illness. Previous guidelines from the Clinical and Laboratory Standards Institute, College of American Pathologists, and others, based on expert opinion and surveys, promoted a limit of ≤3% as acceptable for BCC rates. However, the data supporting such recommendations are controversial. A previous systematic review of BCC examined three practices for reducing BCC rates (venipuncture, phlebotomy teams, and pre-packaged kits). Subsequently, numerous studies on different practices including using diversion devices, disinfectants, and education/training to lower BCC have been published. The goal of the current guideline is to identify beneficial intervention strategies to reduce BCC rates, including devices, practices, and education/training by providers in collaboration with the laboratory. We performed a systematic review of the literature between 2017 and 2022 using numerous databases. Of the 11,319 unique records identified, 311 articles were sought for full-text review, of which 177 were reviewed; 126 of the full-text articles were excluded based on pre-defined inclusion and exclusion criteria. Data were extracted from a total of 49 articles included in the final analysis. An evidenced-based committee's expert panel reviewed all the references as mentioned in Data Collection and determined if the articles met the inclusion criteria. Data from extractions were captured within an extraction template in the US Agency for Healthcare Research and Quality's Systematic Review Data Repository (https://srdr.ahrq.gov/). BCC rates were captured as the number of events (contaminated samples) per arm (standard practice versus improvement practice). Modified versions of the National Heart, Lung, and Blood Institute Study Quality Assessment Tools were used for risk of bias assessment (https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools). We used Grading of Recommendations, Assessment, Development and Evaluations to assess strength of evidence. There are several interventions that resulted in significant reduction in BCC rates: chlorhexidine as a disinfectant for skin preparation, using a diversion device prior to drawing BCs, using sterile technique practices, using a phlebotomy team to obtain BCs, and education/training programs. While there were no substantial differences between methods of decreasing BCC, our results indicate that the method of implementation can determine the success or failure of the intervention. Our evidence-based systematic review and meta-analysis support several interventions to effectively reduce BCC by approximately 40%-60%. However, devices alone without an education/training component and buy-in from key stakeholders to implement various interventions would not be as effective in reducing BCC rates.

Keywords: bacteremia; blood culture contamination; blood cultures; bloodstream infections; practice guidelines; systematic reviews.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Conceptual framework for blood culture contamination analyses. QI, quality improvement.
Fig 2
Fig 2
Preferred Reporting Items for Systematic Reviews and Meta-Analysis flow diagram for the systematic review process.
Fig 3
Fig 3
Summary risk of bias: before–after study designs.
Fig 4
Fig 4
Summary risk of bias: cohort study designs.
Fig 5
Fig 5
Summary risk of bias: controlled study designs.
Fig 6
Fig 6
Forest plot of included studies with chlorhexidine as a skin antiseptic. References are as follows: Nuntnarumit and Sangsuksawang (38), Maeda et al. (41), Ge et al. (43), Kai et al. (34), O’Connor et al. (36), Ryan (37), Marlowe et al. (35), Tangsathapompong et al. (42), Story-Roller and Weinstein (40), and Martinez et al. (39).
Fig 7
Fig 7
Forest plot of studies comparing chlorhexidine with other skin antiseptics, chlorhexidine alone, or chlorhexidine/alcohol. References are as follows: Kai et al. (34), O’Connor et al. (36), Marlowe et al. (35), Tangsathapompong et al. (42), Martinez et al. (39), Nuntnarumit and Sangsuksawang (38), Maeda et al. (41), Ge et al.(43), Ryan (37), and Story-Roller and Weinstein (40).
Fig 8
Fig 8
Forest plot of studies comparing chlorhexidine skin antisepsis in adult or pediatric populations. References are as follows: Nuntnarumit and Sangsuksawang (38), Maeda et al. (41), O’Connor et al. (36), Marlowe et al. (35), Tangsathapompong et al. (42), Ge et al. (43), Kai et al,. (34), Ryan (37), Story-Roller and Weinstein (40), and Martinez et al. (39).
Fig 9
Fig 9
Forest plot of studies examining diversion devices for reducing BCC rates. References are as follows: Rupp et al. (49), Bell et al. (45), Lalezari et al. (46), Zimmerman et al. (48), Patton and Schmitt (47), and Syed et al. (44).
Fig 10
Fig 10
Forest plot of studies on phlebotomy teams and effect on reducing BCC rates. References are as follows: Bae et al. (50) and Santos et al. (51).
Fig 11
Fig 11
Forest plot of studies on using sterile protocols for reducing BCC rates. References are as follows: Frota et al. (52), Self et al. (28, 56), Hall et al. (54), Krajčinović et al. (55), and Kim et al. (53).
Fig 12
Fig 12
Forest plot of studies on the effect of education/training programs on reducing BCC rates. References are as follows: He et al. (60), Halstead et al. (27), Al-Hamad (57), Moeller (63), Sánchez-Sánchez et al.(67), Harding and Bollinger (59), Ramirez et al. (68), Lin et al. (61), Al-Hamad et al. (58), Marini and Truog (62), Park et al. (65), Roth et al. (66), and Murillo et al. (64).
Fig 13
Fig 13
Comparison of probability distributions of BCC reduction rates for high-intensity versus low-intensity training interventions.

References

    1. Chen AI, Bilker WB, Hamilton KW, O’Donnell JA, Nachamkin I. 2018. Blood culture utilization at an academic hospital: addressing a gap in benchmarking. Infect Control Hosp Epidemiol 39:1353–1359. doi:10.1017/ice.2018.231 - DOI - PubMed
    1. Spellberg B. 2020. Edited by Bennett JE, Dolin RBlaseMartin J. Douglas, and Bennett’s principles and practice of infectious diseases. 9th ed, p 211–220. Elsevier, Philadelphia, PA.
    1. Bates DW, Cook EF, Goldman L, Lee TH. 1990. Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med 113:495–500. doi:10.7326/0003-4819-113-7-495 - DOI - PubMed
    1. Doern GV, Carroll KC, Diekema DJ, Garey KW, Rupp ME, Weinstein MP, Sexton DJ. 2019. Practical guidance for clinical microbiology laboratories: a comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the problem. Clin Microbiol Rev 33:00009–00019. doi:10.1128/CMR.00009-19 - DOI - PMC - PubMed
    1. Fabre V, Carroll KC, Cosgrove SE. 2022. Blood culture utilization in the hospital setting: a call for diagnostic stewardship. J Clin Microbiol 60:e0100521. doi:10.1128/JCM.01005-21 - DOI - PMC - PubMed

LinkOut - more resources